RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+9.81%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.89B
Cap. Flow
% of AUM
2.33%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,331
Reduced
595
Closed
62
Top Buys
| 1 |
Apple
AAPL
|
+$183M |
| 2 |
Microsoft
MSFT
|
+$178M |
| 3 |
Amazon
AMZN
|
+$80.9M |
| 4 |
Tesla
TSLA
|
+$59.4M |
| 5 |
GE HealthCare
GEHC
|
+$52M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$37.6M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$18M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| 1 | Technology | 25.38% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
DMC Global
BOOM
$141M
| $1.36M | ﹤0.01% |
61,973
+3,306
| +6% | +$72.7K |
|
2002
Ecovyst
ECVT
$1.05B
| $1.36M | ﹤0.01% |
122,981
+7,247
| +6% | +$80.1K |
|
|
PWSC
2003
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.35M | ﹤0.01% |
68,337
+1,691
| +3% | +$33.5K |
|
2004
ANI Pharmaceuticals
ANIP
$2.11B
| $1.35M | ﹤0.01% |
33,985
+2,382
| +8% | +$94.6K |
|
2005
Viridian Therapeutics
VRDN
$1.62B
| $1.35M | ﹤0.01% |
52,968
+5,715
| +12% | +$145K |
|
2006
Beyond Meat
BYND
$191M
| $1.35M | ﹤0.01% |
82,984
+1,744
| +2% | +$28.3K |
|
|
MORF
2007
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.34M | ﹤0.01% |
35,714
+1,520
| +4% | +$57.2K |
|
2008
Nextracker
NXT
$10B
| $1.33M | ﹤0.01% |
+36,564
| New | +$1.33M |
|
2009
Kearny Financial
KRNY
$415M
| $1.32M | ﹤0.01% |
162,698
+4,117
| +3% | +$33.4K |
|
2010
Johnson Outdoors
JOUT
$416M
| $1.32M | ﹤0.01% |
20,899
-354
| -2% | -$22.3K |
|
2011
Crinetics Pharmaceuticals
CRNX
$3.3B
| $1.32M | ﹤0.01% |
81,904
+2,916
| +4% | +$46.8K |
|
2012
Vanda Pharmaceuticals
VNDA
$265M
| $1.32M | ﹤0.01% |
193,608
+8,485
| +5% | +$57.6K |
|
2013
Marcus Corp
MCS
$485M
| $1.31M | ﹤0.01% |
82,131
+3,762
| +5% | +$60.2K |
|
2014
AngioDynamics
ANGO
$445M
| $1.31M | ﹤0.01% |
126,861
+6,482
| +5% | +$67K |
|
2015
Montrose Environmental
MEG
$1.02B
| $1.31M | ﹤0.01% |
36,712
+1,430
| +4% | +$51K |
|
|
ONL
2016
Orion Office REIT
ONL
$165M
| $1.31M | ﹤0.01% |
195,195
+7,872
| +4% | +$52.8K |
|
2017
Replimune Group
REPL
$468M
| $1.3M | ﹤0.01% |
73,433
+10,770
| +17% | +$190K |
|
2018
IMAX
IMAX
$1.67B
| $1.3M | ﹤0.01% |
67,590
+1,204
| +2% | +$23.1K |
|
|
RDUS
2019
DELISTED
Radius Recycling
RDUS
| $1.28M | ﹤0.01% |
41,218
+1,907
| +5% | +$59.3K |
|
2020
Thermon Group Holdings
THR
$826M
| $1.28M | ﹤0.01% |
51,293
+2,030
| +4% | +$50.6K |
|
2021
Kura Oncology
KURA
$709M
| $1.27M | ﹤0.01% |
104,003
+3,300
| +3% | +$40.4K |
|
2022
First Advantage
FA
$2.74B
| $1.27M | ﹤0.01% |
90,825
+3,352
| +4% | +$46.8K |
|
2023
Cassava Sciences
SAVA
$101M
| $1.27M | ﹤0.01% |
52,553
+781
| +2% | +$18.8K |
|
2024
Playtika
PLTK
$1.39B
| $1.27M | ﹤0.01% |
112,543
+10,287
| +10% | +$116K |
|
2025
GrafTech
EAF
$199M
| $1.27M | ﹤0.01% |
26,021
+959
| +4% | +$46.6K |
|